GL1X · GenesisL1 explorer

MolNFT v1 · #126945 · protein

BTGH84 mutant with covalent modification by MA3

5MI4 · O-glcnacase BT_4395: “BTGH84 mutant with covalent modification by MA3”. X-ray diffraction, 2 ligands (7NQ, CA), 7 pockets (best druggability 0.63). MolNFT v1 #126945 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
5MI4
Type
protein
Length
689 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
O-glcnacase BT_4395
EC
3.2.1.169, 3.2.1.52
UniProt
Q89ZI2
Ligands
7NQ, CA
Pockets
7 · best druggability 0.63

Structure

x-ray diffraction · 1 distinct chain · 39% helix, 21% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AO-glcnacase BT_4395 (EC 3.2.1.169, 3.2.1.52)protein68939% helix, 21% strandQ89ZI2

Ligands and binding sites

  • 7NQ · ~{N}-(4-ethoxyquinazolin-2-yl)propanamide · ligand · chains A
  • CA · Calcium ion · metal · chains A
  • EDO · 1,2-ethanediol · additive · 5 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

7 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14030.630.7850empty
2760.560.8619EDO
3970.390.7613empty
4840.360.7513EDO
51070.360.7416empty

Modifications

Observed in the structure: 1 covalent (covalent ligand).

Compared structures

  • 5MI4 · BtGH84 mutant with covalent modification by MA3 · the same entry in another collection · chain A against A, TM-score 1.00
  • Q89ZI2 · AlphaFold monomer V2.0 prediction for O-glcnacase BT_4395 (Q89ZI2) · a predicted model of the same protein · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.